作者: Irmgard Bumeder , Fuat S. Oduncu , Ralf Schmidmaier , S Fuat
DOI:
关键词:
摘要: Background: Autologous stem cell transplantation is an established therapy for various hematological malignancies. A precondition the efficient and save mobilization of blood cells, which achieved by treatment with granulocytecolony stimulating factors. Previously, it has been demonstrated that pegylated form filgrastim, pegfilgrastim, comparable to filgrastim in efficiency mobilization. Here, we examine, whether a combination pegfilgrastim exerts benefit compared alone safety autologous Patients methods: We retrospectively analyzed data 131 patients undergoing transplantation. The received (n = 66) or 65)